2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on HR+ EBC: Can We De-escalate Adjuvant Chemotherapy Using MammaPrint? What Is the Outcome of Fulvestrant +/- AI vs. AI? Can the new Breast Cancer Index Test Help Identify Patients Who May Benefit from Extended AI Therapy?

474 views
July 16, 2020
Comments 0
Login to view comments. Click here to Login